Myomo, Inc. (MYO)

NYSEAMERICAN: MYO · IEX Real-Time Price · USD
4.060
+0.200 (5.18%)
May 22, 2024, 4:00 PM EDT - Market closed
5.18%
Market Cap 116.99M
Revenue (ttm) 19.55M
Net Income (ttm) -9.34M
Shares Out 28.81M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 586,208
Open 3.830
Previous Close 3.860
Day's Range 3.820 - 4.140
52-Week Range 0.432 - 5.580
Beta 1.50
Analysts Strong Buy
Price Target 4.25 (+4.68%)
Earnings Date May 8, 2024

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jun 12, 2017
Employees 101
Stock Exchange NYSEAMERICAN
Ticker Symbol MYO
Full Company Profile

Financial Performance

In 2023, Myomo's revenue was $19.24 million, an increase of 23.70% compared to the previous year's $15.56 million. Losses were -$8.15 million, -24.00% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 4.68% from the latest price.

Price Target
$4.25
(4.68% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Myomo Reports First Quarter 2024 Financial Results

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

14 days ago - Business Wire

Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

16 days ago - Business Wire

Myomo to Report First Quarter Financial Results on May 8, 2024

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

21 days ago - Business Wire

Myomo Appoints Heather Getz to its Board of Directors

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

7 weeks ago - Business Wire

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

2 months ago - Business Wire

CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

2 months ago - Business Wire

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

2 months ago - Business Wire

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

4 months ago - Business Wire

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

4 months ago - Business Wire

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

4 months ago - Business Wire

Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

7 months ago - Business Wire

CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

7 months ago - Business Wire

Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

7 months ago - Business Wire

Myomo to Report Third Quarter Financial Results on November 7, 2023

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

7 months ago - Business Wire

Myomo Announces Closing of $4.4 Million Public Offering

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

9 months ago - Business Wire

Myomo Announces Pricing of $4.4 Million Public Offering

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

9 months ago - Business Wire

Myomo, Inc. Announces Proposed Public Offering

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

9 months ago - Business Wire

Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

9 months ago - Business Wire

Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

9 months ago - Business Wire

Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

10 months ago - Business Wire

Myomo to Report Second Quarter Financial Results on August 9, 2023

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

10 months ago - Business Wire

Centers for Medicare and Medicaid Services Accepts Myomo's Application to Classify the MyoPro® as a Brace

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

11 months ago - Business Wire

Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

1 year ago - Business Wire

Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

1 year ago - Business Wire

Myomo to Report First Quarter Financial Results on May 10, 2023

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...

1 year ago - Business Wire